Review



annexin v fitc pi apoptosis detection kit  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Elabscience Biotechnology annexin v fitc pi apoptosis detection kit
    Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of <t>apoptosis-related</t> proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by <t>Annexin</t> V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).
    Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 909 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Elabscience Biotechnology
    Average 98 stars, based on 909 article reviews
    annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-06
    98/100 stars

    Images

    1) Product Images from "Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis"

    Article Title: Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.03.062

    Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).
    Figure Legend Snippet: Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).

    Techniques Used: Enzyme-linked Immunosorbent Assay, Western Blot, Expressing, Immunofluorescence, Staining, Flow Cytometry, TUNEL Assay, In Vitro

    The effect of ADO supplements on primary BMSCs. ( A ) MTT assay for the proliferation of BMSCs treated with different doses of ADO for 2 days and 10 days under osteogenic induction conditions with or without 10 μM Dex. ( B-C ) Representative images and quantitative analysis of mineralized nodule areas by Alizarin Red S staining in primary BMSCs treated with gradient doses of ADO under osteogenic induction with or without 10 μM Dex. ( D ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. ( E ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( F ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( G ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( H ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( I ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( J ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 200 μm (B), 50 μm (G), and 25 μm (J).
    Figure Legend Snippet: The effect of ADO supplements on primary BMSCs. ( A ) MTT assay for the proliferation of BMSCs treated with different doses of ADO for 2 days and 10 days under osteogenic induction conditions with or without 10 μM Dex. ( B-C ) Representative images and quantitative analysis of mineralized nodule areas by Alizarin Red S staining in primary BMSCs treated with gradient doses of ADO under osteogenic induction with or without 10 μM Dex. ( D ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. ( E ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( F ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( G ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( H ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( I ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( J ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 200 μm (B), 50 μm (G), and 25 μm (J).

    Techniques Used: MTT Assay, Staining, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Flow Cytometry, TUNEL Assay, In Vitro

    Summary of the study. The schematic diagram illustrates that DUB alleviates GIOP by suppressing oxidative stress and apoptosis via the CD39/CD73/ADO axis and promotes osteogenesis via ADO/A 2b R-mediated activation of the PKA/CREB pathway. The schematic diagram was created by using BioRender.com.
    Figure Legend Snippet: Summary of the study. The schematic diagram illustrates that DUB alleviates GIOP by suppressing oxidative stress and apoptosis via the CD39/CD73/ADO axis and promotes osteogenesis via ADO/A 2b R-mediated activation of the PKA/CREB pathway. The schematic diagram was created by using BioRender.com.

    Techniques Used: Activation Assay



    Similar Products

    96
    Vazyme Biotech Co brightgreen apoptosis detection kit
    Paeonol alleviates D-gal-induced <t>apoptosis</t> in GCs. A-E: qRT-PCR detection of BCL2 , Caspase-3, PCNA, CDK2 , and CCND1 . F-K: Western blot detection of Bax, Bcl-2, PCNA, Caspase-3, and CDK2 proteins. L-M: Annexin V/PI staining and flow cytometry analysis for detection of apoptosis; Q2: Annexin V⁺ / PI⁺, late apoptotic cells; Q3: Annexin V⁺ / PI⁻, early apoptotic cells. Data are presented as mean ± SEM ( n ≥ 3). Different lowercase letters indicate significant differences ( P < 0.05).
    Brightgreen Apoptosis Detection Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brightgreen apoptosis detection kit/product/Vazyme Biotech Co
    Average 96 stars, based on 1 article reviews
    brightgreen apoptosis detection kit - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    97
    Beijing Solarbio Science annexin v fitc pi apoptosis detection kit
    Paeonol alleviates D-gal-induced <t>apoptosis</t> in GCs. A-E: qRT-PCR detection of BCL2 , Caspase-3, PCNA, CDK2 , and CCND1 . F-K: Western blot detection of Bax, Bcl-2, PCNA, Caspase-3, and CDK2 proteins. L-M: Annexin V/PI staining and flow cytometry analysis for detection of apoptosis; Q2: Annexin V⁺ / PI⁺, late apoptotic cells; Q3: Annexin V⁺ / PI⁻, early apoptotic cells. Data are presented as mean ± SEM ( n ≥ 3). Different lowercase letters indicate significant differences ( P < 0.05).
    Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Beijing Solarbio Science
    Average 97 stars, based on 1 article reviews
    annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Beyotime annexin v fitc pi apoptosis detection kit
    Paeonol alleviates D-gal-induced <t>apoptosis</t> in GCs. A-E: qRT-PCR detection of BCL2 , Caspase-3, PCNA, CDK2 , and CCND1 . F-K: Western blot detection of Bax, Bcl-2, PCNA, Caspase-3, and CDK2 proteins. L-M: Annexin V/PI staining and flow cytometry analysis for detection of apoptosis; Q2: Annexin V⁺ / PI⁺, late apoptotic cells; Q3: Annexin V⁺ / PI⁻, early apoptotic cells. Data are presented as mean ± SEM ( n ≥ 3). Different lowercase letters indicate significant differences ( P < 0.05).
    Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Beyotime
    Average 97 stars, based on 1 article reviews
    annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    98
    Elabscience Biotechnology annexin v fitc pi apoptosis detection kit
    Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of <t>apoptosis-related</t> proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by <t>Annexin</t> V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).
    Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Elabscience Biotechnology
    Average 98 stars, based on 1 article reviews
    annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-06
    98/100 stars
      Buy from Supplier

    99
    Beyotime cell apoptosis detection kit
    10 wt% PCL/nHA enhances cell proliferation and reduces <t>apoptosis</t> via calcium ion regulation. (A) Morphological characteristics and viability of L929 cells cultured on PCL and PCL/nHA samples. (B) Statistical evaluation of L929 cells viability. (C) Morphological characteristics and viability of HSFs cultured on PCL and PCL/nHA samples. (D) Statistical evaluation of HSFs viability. (E) Time-dependent proliferation of L929 cells on PCL and PCL/nHA substrates over 1, 2, and 3 days. (F) Time-dependent proliferation of HSFs on PCL and PCL/nHA substrates over 1, 2, and 3 days. (G) Influence of varying nHA concentrations in PCL on L929 cells apoptosis. (H) Quantitative apoptosis assessment across experimental groups based on data from G. (I) Apoptosis of L929 cells cultured in media with varying calcium ion concentrations. (J) Statistical analysis of the apoptosis data presented in I. (K) The morphological characteristics and viability of L929 cells cultured in the CaCl 2 group, the nHA group (with calcium ion concentration equivalent to that in the CaCl 2 group), and the control group. All data are presented as the Mean ± SD (n ≥ 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. ns, no significant difference.
    Cell Apoptosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell apoptosis detection kit/product/Beyotime
    Average 99 stars, based on 1 article reviews
    cell apoptosis detection kit - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Yeasen Biotechnology annexin v fitc pi apoptosis detection kit
    Inhibition of NRF2 results in reduced proliferation and increased <t>apoptosis</t> in chicken PGCs. (A) Morphological observation of PGCs treated with varying concentrations of ML385. Scale bar: 50 μm. (B) Comparison of cell numbers after 3 d of culture in media containing different concentrations of ML385. Different lowercase letters indicate significant differences among groups ( p < 0.05). Based on these dose-dependent effects, the 24 μM concentration was selected for all subsequent experiments. (C and D) Analysis of cell proliferation capacity via EdU assay in ML385-PGCs and Ctrl-PGCs. Scale bar: 50 μm. (E-G) Evaluation of apoptosis levels using <t>Annexin</t> V and PI staining in ML385-PGCs and Ctrl-PGCs. (H and I) Detection of NRF2 protein expression in ML385-PGCs and Ctrl-PGCs by Western blotting. All data are presented as mean ± SEM from three independent biological replicates ( n = 3 per group). Statistical significance is indicated by * ( p < 0.05) and *** ( p < 0.001).
    Annexin V Fitc Pi Apoptosis Detection Kit, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kit/product/Yeasen Biotechnology
    Average 86 stars, based on 1 article reviews
    annexin v fitc pi apoptosis detection kit - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    99
    Beyotime annexin v fitc pi cell apoptosis detection kit
    In vitro therapeutic efficacy and synergy analysis of RPAE-QM in 4 T1 cells. (A) Cell viability of 4 T1 cells incubated with different formulations for 48 h determined by MTT assay. (B) The corresponding IC 50 values of the respective treatments. (C) Representative flow cytometry plots <t>of</t> <t>Annexin</t> <t>V-FITC/PI</t> staining for <t>apoptosis</t> analysis in 4 T1 cells. (D) Quantitative analysis of the total apoptotic rate. (E) Dose-response curves of free Que., free DM1, and their combination used for quantitative synergy determination. (F) The Combination Index (CI) plot as a function of Fraction affected (Fa) generated using the Chou-Talalay method; the reference line at CI = 1 indicates an additive effect, while CI < 1 indicates synergism. Data are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001.
    Annexin V Fitc Pi Cell Apoptosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi cell apoptosis detection kit/product/Beyotime
    Average 99 stars, based on 1 article reviews
    annexin v fitc pi cell apoptosis detection kit - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    97
    Beyotime annexin v fitc apoptosis detection kit
    Knockdown of USP52 causes reduced viability and proliferation, cell cycle arrest, increased <t>apoptosis,</t> and impaired migration and invasion of ccRCC cells. (A) MTT assay data indicates that USP52 deficiency results in reduced viability of 786-O and Caki-1 cells. (B and C) EdU assay results suggest that USP52-deficient 786-O and Caki-1 cells are less proliferative than their control counterparts. (D and E) 7-AAD staining data show that USP52 deficiency causes cell cycle arrest in 786-O and Caki-1 cells. (F, G) <t>Annexin</t> V/PI staining results suggest that USP52 knockdown leads to extra apoptosis in 786-O and Caki-1 cells. (H and I) Transwell assay results show that the migration of 786-O and Caki-1 cells is attenuated by USP52 depletion. (J and K) Transwell assay results indicate that the invasion of USP52-deficient 786-O and Caki-1 cells is mitigated compared to control cells. One-way ANOVA followed by Tukey's HSD was used for P -value calculation.
    Annexin V Fitc Apoptosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc apoptosis detection kit/product/Beyotime
    Average 97 stars, based on 1 article reviews
    annexin v fitc apoptosis detection kit - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    96
    Vazyme Biotech Co tunel brightred apoptosis detection kit
    COPN mitigates oxidative stress, neuroinflammation, and <t>apoptosis</t> in OHT-induced RIRI. a–f , Quantitative analyses of apoptotic markers (TuJ-1, Brn3A, Caspase-3, Bax, Cytochrome-c, and Bcl-2) in retinas subjected to various treatments, which revealed a significant reduction in COPN-induced apoptosis. g , <t>TUNEL</t> assay demonstrating reduced apoptosis in COPN-treated retinas (red fluorescence indicates apoptotic cells, and nuclei are stained with DAPI, blue). h–o , ELISA quantification of proinflammatory cytokines (TNF-α, IL-1β, IFN-γ, IL-18, and MCP-1) and oxidative stress markers (CAT, SOD, MDA, and MCP-1), demonstrating the broad anti-inflammatory and antioxidative effects of COPN. ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Tunel Brightred Apoptosis Detection Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tunel brightred apoptosis detection kit/product/Vazyme Biotech Co
    Average 96 stars, based on 1 article reviews
    tunel brightred apoptosis detection kit - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    98
    Elabscience Biotechnology annexin v fitc pi apoptosis detection kits
    GO-EDM-DTX-Vad combined with NIR induces TNBC cell death, <t>apoptosis</t> and immunogenic cell death. (A, B) Calcein-AM/PI live/dead staining of 4T1 (A) and MDA-MB-231 (B) cells (live, green; dead, red; scale bar, 200 μm). (C, D) <t>Annexin</t> V/PI apoptosis plots for 4T1 (C) and MDA-MB-231 (D) cells. (E, F) Quantification of viable and early/late apoptotic 4T1 cells. (H, I) Quantification of viable and early/late apoptotic MDA-MB-231 cells. (G, J) Dose–response viability curves after 48 h treatment with free DTX or GO-EDM-DTX-Vad in 4T1 (G) and MDA-MB-231 (J). (K, L) Immunofluorescence of CRT exposure and HMGB1 release after 24 h treatment in 4T1 (K) and MDA-MB-231 (L) cells (nuclei, blue; CRT/HMGB1, green; scale bar, 100 μm). (M) Schematic of the ICD-to-DC maturation assay. (N–P) Frequencies of CD40 + , CD80 + and CD86 + DCs after co-culture. Data are mean ± SD (n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001; ns, not significant.
    Annexin V Fitc Pi Apoptosis Detection Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/annexin v fitc pi apoptosis detection kits/product/Elabscience Biotechnology
    Average 98 stars, based on 1 article reviews
    annexin v fitc pi apoptosis detection kits - by Bioz Stars, 2026-06
    98/100 stars
      Buy from Supplier

    Image Search Results


    Paeonol alleviates D-gal-induced apoptosis in GCs. A-E: qRT-PCR detection of BCL2 , Caspase-3, PCNA, CDK2 , and CCND1 . F-K: Western blot detection of Bax, Bcl-2, PCNA, Caspase-3, and CDK2 proteins. L-M: Annexin V/PI staining and flow cytometry analysis for detection of apoptosis; Q2: Annexin V⁺ / PI⁺, late apoptotic cells; Q3: Annexin V⁺ / PI⁻, early apoptotic cells. Data are presented as mean ± SEM ( n ≥ 3). Different lowercase letters indicate significant differences ( P < 0.05).

    Journal: Poultry Science

    Article Title: Paeonol alleviates granulosa cell senescence in laying chickens via the PI3K/Akt/mTOR signaling pathway

    doi: 10.1016/j.psj.2026.106750

    Figure Lengend Snippet: Paeonol alleviates D-gal-induced apoptosis in GCs. A-E: qRT-PCR detection of BCL2 , Caspase-3, PCNA, CDK2 , and CCND1 . F-K: Western blot detection of Bax, Bcl-2, PCNA, Caspase-3, and CDK2 proteins. L-M: Annexin V/PI staining and flow cytometry analysis for detection of apoptosis; Q2: Annexin V⁺ / PI⁺, late apoptotic cells; Q3: Annexin V⁺ / PI⁻, early apoptotic cells. Data are presented as mean ± SEM ( n ≥ 3). Different lowercase letters indicate significant differences ( P < 0.05).

    Article Snippet: Deparaffinized sections were processed using a BrightGreen Apoptosis Detection Kit (A112-03, Vazyme, Nanjing, China) according to the manufacturer's protocol.

    Techniques: Quantitative RT-PCR, Western Blot, Staining, Flow Cytometry

    Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).

    Journal: Bioactive Materials

    Article Title: Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis

    doi: 10.1016/j.bioactmat.2026.03.062

    Figure Lengend Snippet: Roles of the CD39/CD73 axis on DUB's multidirectional protection effects in Dex-treated primary BMSCs. ( A ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( B ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( C ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( D ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( E ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( F ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). ( G ) Representative images and quantitative analysis of Alizarin Red S staining for mineralization in primary BMSCs of different groups under osteogenic conditions. ( H ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 50 μm (C), 25 μm (F), and 200 μm (G).

    Article Snippet: The proportion of early and late apoptotic primary BMSCs under different treatment conditions was determined using an Annexin V-FITC/PI Apoptosis Detection Kit (E-CK-A211, Elabscience, Wuhan, China).

    Techniques: Enzyme-linked Immunosorbent Assay, Western Blot, Expressing, Immunofluorescence, Staining, Flow Cytometry, TUNEL Assay, In Vitro

    The effect of ADO supplements on primary BMSCs. ( A ) MTT assay for the proliferation of BMSCs treated with different doses of ADO for 2 days and 10 days under osteogenic induction conditions with or without 10 μM Dex. ( B-C ) Representative images and quantitative analysis of mineralized nodule areas by Alizarin Red S staining in primary BMSCs treated with gradient doses of ADO under osteogenic induction with or without 10 μM Dex. ( D ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. ( E ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( F ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( G ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( H ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( I ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( J ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 200 μm (B), 50 μm (G), and 25 μm (J).

    Journal: Bioactive Materials

    Article Title: Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis

    doi: 10.1016/j.bioactmat.2026.03.062

    Figure Lengend Snippet: The effect of ADO supplements on primary BMSCs. ( A ) MTT assay for the proliferation of BMSCs treated with different doses of ADO for 2 days and 10 days under osteogenic induction conditions with or without 10 μM Dex. ( B-C ) Representative images and quantitative analysis of mineralized nodule areas by Alizarin Red S staining in primary BMSCs treated with gradient doses of ADO under osteogenic induction with or without 10 μM Dex. ( D ) Western blot and quantification for the expression of osteogenesis-related proteins in primary BMSCs of different groups. ( E ) ELISA for ROS clearance-related enzyme T-SOD and ROS damage biomarkers 8-OHdG, AOPP, and MDA in primary BMSCs of different groups. ( F ) Western blot and quantification for the expression of ROS clearance-related proteins in primary BMSCs of different groups. ( G ) Representative images and quantitative analysis of immunofluorescence staining for MitoSox (red) in primary BMSCs of different groups, and nuclei were stained with Hoechst (blue). ( H ) Western blot and quantification for the expression of apoptosis-related proteins in primary BMSCs of different groups. ( I ) Cellular apoptosis detection in primary BMSCs of different groups by Annexin V-FITC and PI dual-staining assessment via flow cytometry. The proportion of cells in each quadrant was indicated in the plot. ( J ) Tunel (red) staining and quantification of apoptotic cells in primary BMSCs of different groups, and nuclei were stained with DAPI (blue). n = 4 independent repeats by using different biological samples in each group for in vitro experiments. Data were means ± s.e.m. ∗∗ p < 0.01, ∗∗∗ p < 0.001 by one-way ANOVA. Scale bars: 200 μm (B), 50 μm (G), and 25 μm (J).

    Article Snippet: The proportion of early and late apoptotic primary BMSCs under different treatment conditions was determined using an Annexin V-FITC/PI Apoptosis Detection Kit (E-CK-A211, Elabscience, Wuhan, China).

    Techniques: MTT Assay, Staining, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Flow Cytometry, TUNEL Assay, In Vitro

    Summary of the study. The schematic diagram illustrates that DUB alleviates GIOP by suppressing oxidative stress and apoptosis via the CD39/CD73/ADO axis and promotes osteogenesis via ADO/A 2b R-mediated activation of the PKA/CREB pathway. The schematic diagram was created by using BioRender.com.

    Journal: Bioactive Materials

    Article Title: Screening of a quinonoid compounds library identifies decylubiquinone as an antioxidant and anti-apoptotic agent against glucocorticoid-induced osteoporosis via CD39/CD73/adenosine axis

    doi: 10.1016/j.bioactmat.2026.03.062

    Figure Lengend Snippet: Summary of the study. The schematic diagram illustrates that DUB alleviates GIOP by suppressing oxidative stress and apoptosis via the CD39/CD73/ADO axis and promotes osteogenesis via ADO/A 2b R-mediated activation of the PKA/CREB pathway. The schematic diagram was created by using BioRender.com.

    Article Snippet: The proportion of early and late apoptotic primary BMSCs under different treatment conditions was determined using an Annexin V-FITC/PI Apoptosis Detection Kit (E-CK-A211, Elabscience, Wuhan, China).

    Techniques: Activation Assay

    10 wt% PCL/nHA enhances cell proliferation and reduces apoptosis via calcium ion regulation. (A) Morphological characteristics and viability of L929 cells cultured on PCL and PCL/nHA samples. (B) Statistical evaluation of L929 cells viability. (C) Morphological characteristics and viability of HSFs cultured on PCL and PCL/nHA samples. (D) Statistical evaluation of HSFs viability. (E) Time-dependent proliferation of L929 cells on PCL and PCL/nHA substrates over 1, 2, and 3 days. (F) Time-dependent proliferation of HSFs on PCL and PCL/nHA substrates over 1, 2, and 3 days. (G) Influence of varying nHA concentrations in PCL on L929 cells apoptosis. (H) Quantitative apoptosis assessment across experimental groups based on data from G. (I) Apoptosis of L929 cells cultured in media with varying calcium ion concentrations. (J) Statistical analysis of the apoptosis data presented in I. (K) The morphological characteristics and viability of L929 cells cultured in the CaCl 2 group, the nHA group (with calcium ion concentration equivalent to that in the CaCl 2 group), and the control group. All data are presented as the Mean ± SD (n ≥ 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. ns, no significant difference.

    Journal: Bioactive Materials

    Article Title: Three-dimensional printed PCL/nHA scaffolds promote soft tissue functional fibrosis to repair chest wall defect via Piezo1/Ca 2+ signal during respiratory motion

    doi: 10.1016/j.bioactmat.2026.03.037

    Figure Lengend Snippet: 10 wt% PCL/nHA enhances cell proliferation and reduces apoptosis via calcium ion regulation. (A) Morphological characteristics and viability of L929 cells cultured on PCL and PCL/nHA samples. (B) Statistical evaluation of L929 cells viability. (C) Morphological characteristics and viability of HSFs cultured on PCL and PCL/nHA samples. (D) Statistical evaluation of HSFs viability. (E) Time-dependent proliferation of L929 cells on PCL and PCL/nHA substrates over 1, 2, and 3 days. (F) Time-dependent proliferation of HSFs on PCL and PCL/nHA substrates over 1, 2, and 3 days. (G) Influence of varying nHA concentrations in PCL on L929 cells apoptosis. (H) Quantitative apoptosis assessment across experimental groups based on data from G. (I) Apoptosis of L929 cells cultured in media with varying calcium ion concentrations. (J) Statistical analysis of the apoptosis data presented in I. (K) The morphological characteristics and viability of L929 cells cultured in the CaCl 2 group, the nHA group (with calcium ion concentration equivalent to that in the CaCl 2 group), and the control group. All data are presented as the Mean ± SD (n ≥ 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. ns, no significant difference.

    Article Snippet: CCK-8 assay kit, Fluo-4AM, Cell Apoptosis Detection Kit, Mitochondrial membrane potential assay kit and ROS Assay Kit were purchased from Beyotime Biotechnology (China).

    Techniques: Cell Culture, Concentration Assay, Control

    Piezo1-mediated Ca 2+ signaling in PCL/nHA-Driven cell behaviors. (A) Fluorescence imaging of intracellular calcium ion influx in L929 cells on PCL and PCL/nHA surfaces. (B) Fluorescence quantification of calcium ion influx in A. (C) Fluorescence imaging of intracellular calcium ion influx in HSFs on PCL and PCL/nHA surfaces. (D) Fluorescence quantification of calcium ion influx in C. (E) Fluorescence imaging assessment of intracellular ROS levels in L929 cells on PCL and PCL/nHA samples. (F) Effects of PCL samples with different nHA contents on the mitochondrial membrane potential of L929 cells. (G) Assessment of the expression levels of mechanosensing- and proliferation-related proteins in L929 cells cultured on PCL and PCL/nHA surfaces. (H) Assessment of the expression levels of mechanosensing- and proliferation-related proteins in HSFs cultured on PCL and PCL/nHA surfaces. (I) Assessment of the expression levels of apoptosis-related proteins in L929 cells cultured on PCL and PCL/nHA surfaces. (J) Schematic illustration depicting the mechanisms underlying L929 cell proliferation differences. All data are presented as the Mean ± SD (n ≥ 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. ns, no significant difference.

    Journal: Bioactive Materials

    Article Title: Three-dimensional printed PCL/nHA scaffolds promote soft tissue functional fibrosis to repair chest wall defect via Piezo1/Ca 2+ signal during respiratory motion

    doi: 10.1016/j.bioactmat.2026.03.037

    Figure Lengend Snippet: Piezo1-mediated Ca 2+ signaling in PCL/nHA-Driven cell behaviors. (A) Fluorescence imaging of intracellular calcium ion influx in L929 cells on PCL and PCL/nHA surfaces. (B) Fluorescence quantification of calcium ion influx in A. (C) Fluorescence imaging of intracellular calcium ion influx in HSFs on PCL and PCL/nHA surfaces. (D) Fluorescence quantification of calcium ion influx in C. (E) Fluorescence imaging assessment of intracellular ROS levels in L929 cells on PCL and PCL/nHA samples. (F) Effects of PCL samples with different nHA contents on the mitochondrial membrane potential of L929 cells. (G) Assessment of the expression levels of mechanosensing- and proliferation-related proteins in L929 cells cultured on PCL and PCL/nHA surfaces. (H) Assessment of the expression levels of mechanosensing- and proliferation-related proteins in HSFs cultured on PCL and PCL/nHA surfaces. (I) Assessment of the expression levels of apoptosis-related proteins in L929 cells cultured on PCL and PCL/nHA surfaces. (J) Schematic illustration depicting the mechanisms underlying L929 cell proliferation differences. All data are presented as the Mean ± SD (n ≥ 3). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. ns, no significant difference.

    Article Snippet: CCK-8 assay kit, Fluo-4AM, Cell Apoptosis Detection Kit, Mitochondrial membrane potential assay kit and ROS Assay Kit were purchased from Beyotime Biotechnology (China).

    Techniques: Fluorescence, Imaging, Membrane, Expressing, Cell Culture

    Inhibition of NRF2 results in reduced proliferation and increased apoptosis in chicken PGCs. (A) Morphological observation of PGCs treated with varying concentrations of ML385. Scale bar: 50 μm. (B) Comparison of cell numbers after 3 d of culture in media containing different concentrations of ML385. Different lowercase letters indicate significant differences among groups ( p < 0.05). Based on these dose-dependent effects, the 24 μM concentration was selected for all subsequent experiments. (C and D) Analysis of cell proliferation capacity via EdU assay in ML385-PGCs and Ctrl-PGCs. Scale bar: 50 μm. (E-G) Evaluation of apoptosis levels using Annexin V and PI staining in ML385-PGCs and Ctrl-PGCs. (H and I) Detection of NRF2 protein expression in ML385-PGCs and Ctrl-PGCs by Western blotting. All data are presented as mean ± SEM from three independent biological replicates ( n = 3 per group). Statistical significance is indicated by * ( p < 0.05) and *** ( p < 0.001).

    Journal: Poultry Science

    Article Title: NRF2 deficiency impairs proliferation and survival of chicken primordial germ cells via oxidative stress, mitochondrial dysfunction and apoptosis

    doi: 10.1016/j.psj.2026.106765

    Figure Lengend Snippet: Inhibition of NRF2 results in reduced proliferation and increased apoptosis in chicken PGCs. (A) Morphological observation of PGCs treated with varying concentrations of ML385. Scale bar: 50 μm. (B) Comparison of cell numbers after 3 d of culture in media containing different concentrations of ML385. Different lowercase letters indicate significant differences among groups ( p < 0.05). Based on these dose-dependent effects, the 24 μM concentration was selected for all subsequent experiments. (C and D) Analysis of cell proliferation capacity via EdU assay in ML385-PGCs and Ctrl-PGCs. Scale bar: 50 μm. (E-G) Evaluation of apoptosis levels using Annexin V and PI staining in ML385-PGCs and Ctrl-PGCs. (H and I) Detection of NRF2 protein expression in ML385-PGCs and Ctrl-PGCs by Western blotting. All data are presented as mean ± SEM from three independent biological replicates ( n = 3 per group). Statistical significance is indicated by * ( p < 0.05) and *** ( p < 0.001).

    Article Snippet: Apoptosis was assessed using the Annexin V‐FITC/PI Apoptosis Detection Kit (40302ES50, Yeasen, Shanghai, China) according to the manufacturer's instructions.

    Techniques: Inhibition, Comparison, Concentration Assay, EdU Assay, Staining, Expressing, Western Blot

    RNA sequencing analysis reveals aberrant expression of genes related to cell growth, cell cycle, and apoptosis induced by NRF2 inhibition. GSEA of genes related to cell growth (A), cell cycle (B), and apoptosis (C and D) in ML385-PGCs and Ctrl-PGCs. Heatmap (E) depicting the expression of apoptosis pathway genes between ML385-PGCs and Ctrl-PGCs. Comparative analysis (F) of normalized FPKM values of apoptosis pathway genes between ML385-PGCs and Ctrl-PGCs. Statistical significance is indicated by * ( p < 0.05).

    Journal: Poultry Science

    Article Title: NRF2 deficiency impairs proliferation and survival of chicken primordial germ cells via oxidative stress, mitochondrial dysfunction and apoptosis

    doi: 10.1016/j.psj.2026.106765

    Figure Lengend Snippet: RNA sequencing analysis reveals aberrant expression of genes related to cell growth, cell cycle, and apoptosis induced by NRF2 inhibition. GSEA of genes related to cell growth (A), cell cycle (B), and apoptosis (C and D) in ML385-PGCs and Ctrl-PGCs. Heatmap (E) depicting the expression of apoptosis pathway genes between ML385-PGCs and Ctrl-PGCs. Comparative analysis (F) of normalized FPKM values of apoptosis pathway genes between ML385-PGCs and Ctrl-PGCs. Statistical significance is indicated by * ( p < 0.05).

    Article Snippet: Apoptosis was assessed using the Annexin V‐FITC/PI Apoptosis Detection Kit (40302ES50, Yeasen, Shanghai, China) according to the manufacturer's instructions.

    Techniques: RNA Sequencing, Expressing, Inhibition

    Schematic representation illustrating the impact of NRF2 deficiency on chicken PGCs. NRF2 plays a critical role in maintaining the normal growth of PGCs during in vitro culture by activating antioxidant pathways. NRF2 deficiency impairs antioxidant defense, leading to oxidative stress, mitochondrial damage, and increased apoptosis. Additionally, mitophagy and autophagy are activated to remove damaged organelles. Furthermore, elevated ferroptosis markers, including oxidative stress‑induced lipid peroxidation and Fe²⁺ accumulation, are observed, contributing to reduced PGC viability. Δψm denotes mitochondrial membrane potential.

    Journal: Poultry Science

    Article Title: NRF2 deficiency impairs proliferation and survival of chicken primordial germ cells via oxidative stress, mitochondrial dysfunction and apoptosis

    doi: 10.1016/j.psj.2026.106765

    Figure Lengend Snippet: Schematic representation illustrating the impact of NRF2 deficiency on chicken PGCs. NRF2 plays a critical role in maintaining the normal growth of PGCs during in vitro culture by activating antioxidant pathways. NRF2 deficiency impairs antioxidant defense, leading to oxidative stress, mitochondrial damage, and increased apoptosis. Additionally, mitophagy and autophagy are activated to remove damaged organelles. Furthermore, elevated ferroptosis markers, including oxidative stress‑induced lipid peroxidation and Fe²⁺ accumulation, are observed, contributing to reduced PGC viability. Δψm denotes mitochondrial membrane potential.

    Article Snippet: Apoptosis was assessed using the Annexin V‐FITC/PI Apoptosis Detection Kit (40302ES50, Yeasen, Shanghai, China) according to the manufacturer's instructions.

    Techniques: In Vitro, Membrane

    In vitro therapeutic efficacy and synergy analysis of RPAE-QM in 4 T1 cells. (A) Cell viability of 4 T1 cells incubated with different formulations for 48 h determined by MTT assay. (B) The corresponding IC 50 values of the respective treatments. (C) Representative flow cytometry plots of Annexin V-FITC/PI staining for apoptosis analysis in 4 T1 cells. (D) Quantitative analysis of the total apoptotic rate. (E) Dose-response curves of free Que., free DM1, and their combination used for quantitative synergy determination. (F) The Combination Index (CI) plot as a function of Fraction affected (Fa) generated using the Chou-Talalay method; the reference line at CI = 1 indicates an additive effect, while CI < 1 indicates synergism. Data are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001.

    Journal: International Journal of Pharmaceutics: X

    Article Title: A pH-responsive dual-drug nanoplatform for stromal remodeling and enhanced chemotherapy via MMP3/TGF- β inhibition

    doi: 10.1016/j.ijpx.2026.100489

    Figure Lengend Snippet: In vitro therapeutic efficacy and synergy analysis of RPAE-QM in 4 T1 cells. (A) Cell viability of 4 T1 cells incubated with different formulations for 48 h determined by MTT assay. (B) The corresponding IC 50 values of the respective treatments. (C) Representative flow cytometry plots of Annexin V-FITC/PI staining for apoptosis analysis in 4 T1 cells. (D) Quantitative analysis of the total apoptotic rate. (E) Dose-response curves of free Que., free DM1, and their combination used for quantitative synergy determination. (F) The Combination Index (CI) plot as a function of Fraction affected (Fa) generated using the Chou-Talalay method; the reference line at CI = 1 indicates an additive effect, while CI < 1 indicates synergism. Data are presented as mean ± SD (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001.

    Article Snippet: After 24 h, the cells were harvested and stained with Annexin V-FITC/PI Cell Apoptosis Detection Kit (Beyotime, China) for flow cytometer analysis.

    Techniques: In Vitro, Drug discovery, Incubation, MTT Assay, Flow Cytometry, Staining, Generated

    Knockdown of USP52 causes reduced viability and proliferation, cell cycle arrest, increased apoptosis, and impaired migration and invasion of ccRCC cells. (A) MTT assay data indicates that USP52 deficiency results in reduced viability of 786-O and Caki-1 cells. (B and C) EdU assay results suggest that USP52-deficient 786-O and Caki-1 cells are less proliferative than their control counterparts. (D and E) 7-AAD staining data show that USP52 deficiency causes cell cycle arrest in 786-O and Caki-1 cells. (F, G) Annexin V/PI staining results suggest that USP52 knockdown leads to extra apoptosis in 786-O and Caki-1 cells. (H and I) Transwell assay results show that the migration of 786-O and Caki-1 cells is attenuated by USP52 depletion. (J and K) Transwell assay results indicate that the invasion of USP52-deficient 786-O and Caki-1 cells is mitigated compared to control cells. One-way ANOVA followed by Tukey's HSD was used for P -value calculation.

    Journal: Translational Oncology

    Article Title: USP52 promotes clear cell renal carcinoma progression by deubiquitinating and stabilizing CORO6

    doi: 10.1016/j.tranon.2026.102773

    Figure Lengend Snippet: Knockdown of USP52 causes reduced viability and proliferation, cell cycle arrest, increased apoptosis, and impaired migration and invasion of ccRCC cells. (A) MTT assay data indicates that USP52 deficiency results in reduced viability of 786-O and Caki-1 cells. (B and C) EdU assay results suggest that USP52-deficient 786-O and Caki-1 cells are less proliferative than their control counterparts. (D and E) 7-AAD staining data show that USP52 deficiency causes cell cycle arrest in 786-O and Caki-1 cells. (F, G) Annexin V/PI staining results suggest that USP52 knockdown leads to extra apoptosis in 786-O and Caki-1 cells. (H and I) Transwell assay results show that the migration of 786-O and Caki-1 cells is attenuated by USP52 depletion. (J and K) Transwell assay results indicate that the invasion of USP52-deficient 786-O and Caki-1 cells is mitigated compared to control cells. One-way ANOVA followed by Tukey's HSD was used for P -value calculation.

    Article Snippet: Cell apoptosis was assessed using the Annexin V-FITC apoptosis detection kit (Beyotime Biotechnology) following the manufacturer's instructions.

    Techniques: Knockdown, Migration, MTT Assay, EdU Assay, Control, Staining, Transwell Assay

    Overexpression of CORO6 restores the malignancy of USP52-deficient ccRCC cells. (A and B) 7-AAD staining data reveal that excessive CORO6 facilitates cell cycle progression in USP52-deficient 786-O and Caki-1 cells. (C and D) Annexin V/PI staining assay data indicate that excessive CORO6 decreases the apoptosis of 786-O and Caki-1 cells with USP52 deficiency. (E and F) Transwell assay results show that overexpression of CORO6 strengthens the migration of USP52-deficient 786-O and Caki-1 cells. (G and H) Transwell assay results demonstrate that excessive CORO6 enhances the invasion of USP52-deficient 786-O and Caki-1 cells. One-way ANOVA followed by Tukey's HSD was used for P -value calculation.

    Journal: Translational Oncology

    Article Title: USP52 promotes clear cell renal carcinoma progression by deubiquitinating and stabilizing CORO6

    doi: 10.1016/j.tranon.2026.102773

    Figure Lengend Snippet: Overexpression of CORO6 restores the malignancy of USP52-deficient ccRCC cells. (A and B) 7-AAD staining data reveal that excessive CORO6 facilitates cell cycle progression in USP52-deficient 786-O and Caki-1 cells. (C and D) Annexin V/PI staining assay data indicate that excessive CORO6 decreases the apoptosis of 786-O and Caki-1 cells with USP52 deficiency. (E and F) Transwell assay results show that overexpression of CORO6 strengthens the migration of USP52-deficient 786-O and Caki-1 cells. (G and H) Transwell assay results demonstrate that excessive CORO6 enhances the invasion of USP52-deficient 786-O and Caki-1 cells. One-way ANOVA followed by Tukey's HSD was used for P -value calculation.

    Article Snippet: Cell apoptosis was assessed using the Annexin V-FITC apoptosis detection kit (Beyotime Biotechnology) following the manufacturer's instructions.

    Techniques: Over Expression, Staining, Transwell Assay, Migration

    COPN mitigates oxidative stress, neuroinflammation, and apoptosis in OHT-induced RIRI. a–f , Quantitative analyses of apoptotic markers (TuJ-1, Brn3A, Caspase-3, Bax, Cytochrome-c, and Bcl-2) in retinas subjected to various treatments, which revealed a significant reduction in COPN-induced apoptosis. g , TUNEL assay demonstrating reduced apoptosis in COPN-treated retinas (red fluorescence indicates apoptotic cells, and nuclei are stained with DAPI, blue). h–o , ELISA quantification of proinflammatory cytokines (TNF-α, IL-1β, IFN-γ, IL-18, and MCP-1) and oxidative stress markers (CAT, SOD, MDA, and MCP-1), demonstrating the broad anti-inflammatory and antioxidative effects of COPN. ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: A dual-responsive CO-releasing nanogel ameliorates retinal ischemia–reperfusion injury by restoring mitochondrial homeostasis and attenuating cGAS-STING pathway activation

    doi: 10.1016/j.mtbio.2026.102974

    Figure Lengend Snippet: COPN mitigates oxidative stress, neuroinflammation, and apoptosis in OHT-induced RIRI. a–f , Quantitative analyses of apoptotic markers (TuJ-1, Brn3A, Caspase-3, Bax, Cytochrome-c, and Bcl-2) in retinas subjected to various treatments, which revealed a significant reduction in COPN-induced apoptosis. g , TUNEL assay demonstrating reduced apoptosis in COPN-treated retinas (red fluorescence indicates apoptotic cells, and nuclei are stained with DAPI, blue). h–o , ELISA quantification of proinflammatory cytokines (TNF-α, IL-1β, IFN-γ, IL-18, and MCP-1) and oxidative stress markers (CAT, SOD, MDA, and MCP-1), demonstrating the broad anti-inflammatory and antioxidative effects of COPN. ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was performed via the TUNEL BrightRed Apoptosis Detection Kit (Vazyme, Cat# A113-01) according to the manufacturer's instructions.

    Techniques: TUNEL Assay, Fluorescence, Staining, Enzyme-linked Immunosorbent Assay

    COPN mitigates retinal ischemia‒reperfusion injury by suppressing the cGAS–STING–TBK1 signaling axis. a , Heatmap illustrating the differential expression of key genes involved in mitochondrial function, apoptosis, and inflammatory responses between OHT-treated and control retinas. b , Gene Ontology (GO) enrichment analysis highlighting significantly enriched biological processes and molecular functions, including the mitochondrial stress response, cGAS-STING complex activation, and neuroinflammation. c , Volcano plot depicting significantly differentially expressed genes (DEGs) between the OHT and control groups, with upregulated genes in red and downregulated genes in blue. d , KEGG pathway enrichment analysis revealed significant activation of oxidative phosphorylation disruption, apoptosis, inflammation, and notably the cGAS‒STING signaling pathway in retinal ischemia. e , RT‒qPCR quantification of key components of the cGAS‒STING pathway (cGAS, STING, TBK1, IRF3, and caspase-3) in the retinas of mice after different treatments. f–g , Western blot analyses of cGAS-STING pathway-related proteins (cGAS, STING, p-STING, TBK1, p-TBK1, IRF3, p-IRF3, and cleaved caspase-3) under (f) OGD/R stress in R28 cells and (g) retinal tissues from OHT mice. ∗∗∗∗ P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: A dual-responsive CO-releasing nanogel ameliorates retinal ischemia–reperfusion injury by restoring mitochondrial homeostasis and attenuating cGAS-STING pathway activation

    doi: 10.1016/j.mtbio.2026.102974

    Figure Lengend Snippet: COPN mitigates retinal ischemia‒reperfusion injury by suppressing the cGAS–STING–TBK1 signaling axis. a , Heatmap illustrating the differential expression of key genes involved in mitochondrial function, apoptosis, and inflammatory responses between OHT-treated and control retinas. b , Gene Ontology (GO) enrichment analysis highlighting significantly enriched biological processes and molecular functions, including the mitochondrial stress response, cGAS-STING complex activation, and neuroinflammation. c , Volcano plot depicting significantly differentially expressed genes (DEGs) between the OHT and control groups, with upregulated genes in red and downregulated genes in blue. d , KEGG pathway enrichment analysis revealed significant activation of oxidative phosphorylation disruption, apoptosis, inflammation, and notably the cGAS‒STING signaling pathway in retinal ischemia. e , RT‒qPCR quantification of key components of the cGAS‒STING pathway (cGAS, STING, TBK1, IRF3, and caspase-3) in the retinas of mice after different treatments. f–g , Western blot analyses of cGAS-STING pathway-related proteins (cGAS, STING, p-STING, TBK1, p-TBK1, IRF3, p-IRF3, and cleaved caspase-3) under (f) OGD/R stress in R28 cells and (g) retinal tissues from OHT mice. ∗∗∗∗ P < 0.0001. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was performed via the TUNEL BrightRed Apoptosis Detection Kit (Vazyme, Cat# A113-01) according to the manufacturer's instructions.

    Techniques: Quantitative Proteomics, Control, Activation Assay, Phospho-proteomics, Disruption, Western Blot

    GO-EDM-DTX-Vad combined with NIR induces TNBC cell death, apoptosis and immunogenic cell death. (A, B) Calcein-AM/PI live/dead staining of 4T1 (A) and MDA-MB-231 (B) cells (live, green; dead, red; scale bar, 200 μm). (C, D) Annexin V/PI apoptosis plots for 4T1 (C) and MDA-MB-231 (D) cells. (E, F) Quantification of viable and early/late apoptotic 4T1 cells. (H, I) Quantification of viable and early/late apoptotic MDA-MB-231 cells. (G, J) Dose–response viability curves after 48 h treatment with free DTX or GO-EDM-DTX-Vad in 4T1 (G) and MDA-MB-231 (J). (K, L) Immunofluorescence of CRT exposure and HMGB1 release after 24 h treatment in 4T1 (K) and MDA-MB-231 (L) cells (nuclei, blue; CRT/HMGB1, green; scale bar, 100 μm). (M) Schematic of the ICD-to-DC maturation assay. (N–P) Frequencies of CD40 + , CD80 + and CD86 + DCs after co-culture. Data are mean ± SD (n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001; ns, not significant.

    Journal: Materials Today Bio

    Article Title: Mannosylated graphene oxide nanotherapeutics co-delivering docetaxel and a STING agonist reprogram myeloid cells and potentiate antitumor immunity

    doi: 10.1016/j.mtbio.2026.103086

    Figure Lengend Snippet: GO-EDM-DTX-Vad combined with NIR induces TNBC cell death, apoptosis and immunogenic cell death. (A, B) Calcein-AM/PI live/dead staining of 4T1 (A) and MDA-MB-231 (B) cells (live, green; dead, red; scale bar, 200 μm). (C, D) Annexin V/PI apoptosis plots for 4T1 (C) and MDA-MB-231 (D) cells. (E, F) Quantification of viable and early/late apoptotic 4T1 cells. (H, I) Quantification of viable and early/late apoptotic MDA-MB-231 cells. (G, J) Dose–response viability curves after 48 h treatment with free DTX or GO-EDM-DTX-Vad in 4T1 (G) and MDA-MB-231 (J). (K, L) Immunofluorescence of CRT exposure and HMGB1 release after 24 h treatment in 4T1 (K) and MDA-MB-231 (L) cells (nuclei, blue; CRT/HMGB1, green; scale bar, 100 μm). (M) Schematic of the ICD-to-DC maturation assay. (N–P) Frequencies of CD40 + , CD80 + and CD86 + DCs after co-culture. Data are mean ± SD (n = 3). ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001; ns, not significant.

    Article Snippet: Annexin V-FITC/PI apoptosis detection kits were purchased from Elabscience Biotechnology Co., Ltd. (Wuhan, China).

    Techniques: Staining, Immunofluorescence, Co-Culture Assay